Cargando…
Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial)
In patients on chronic hemodialysis, there is no standard protocol for maintenance iron supplementation. This study aimed to compare two fixed-dose intravenous (IV) iron protocols to reduce erythropoiesis-stimulating agents (ESA). We conducted a double-blinded, randomized controlled study on hemodia...
Autores principales: | Anumas, Suthiya, Chatkrailert, Aphichat, Tantiyavarong, Pichaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870895/ https://www.ncbi.nlm.nih.gov/pubmed/36690782 http://dx.doi.org/10.1038/s41598-023-28440-3 |
Ejemplares similares
-
Predictors for Unsuccessful Reductions in Hemodialysis Frequency during the Pandemic
por: Anumas, Suthiya, et al.
Publicado: (2023) -
The Association of Beta-Blocker Use and Bone Mineral Density Level in Hemodialysis Patients: A Cross-Sectional Study
por: Anumas, Suthiya, et al.
Publicado: (2023) -
The Prediction Score of Acute Kidney Injury in Patients with Severe COVID-19 Infection
por: Anumas, Suthiya, et al.
Publicado: (2023) -
Effect of Maintenance Intravenous Iron Treatment on Erythropoietin
Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled
Trial
por: Susantitaphong, Paweena, et al.
Publicado: (2020) -
Predictors of iron versus erythropoietin responsiveness in anemic hemodialysis patients
por: Hildebrand, Sarah, et al.
Publicado: (2022)